Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypoprothrombinemia: case report.

R R Montgomery, A Otsuka, W E Hathaway

    Blood
    |February 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    A patient with hypoprothrombinemia had significantly low prothrombin (factor II) levels. Despite low activity, his prothrombin protein was structurally normal, indicating a functional defect.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study).

    ESMO open·2021
    Same author

    Inducible skin-associated lymphoid tissue (iSALT) in a patient with Schnitzler syndrome who manifested wheals on recurrent localized erythema.

    The British journal of dermatology·2021
    Same author

    Demographic and clinical characteristics of extramammary Paget's disease patients in Japan from 2000 to 2019.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2020
    Same author

    Atypical blue naevus of the labium minus confirmed by whole-exome sequencing.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2020
    Same author

    Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients.

    Annals of oncology : official journal of the European Society for Medical Oncology·2020
    Same author

    The efficacy of eribulin mesylate for patients with cutaneous angiosarcoma previously treated with taxane: a multicentre prospective observational study.

    The British journal of dermatology·2020
    Same journal

    Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

    Blood·2026
    Same journal

    Identifying steroid-refractory aGVHD before it happens.

    Blood·2026
    Same journal

    ELISA-negative HIT: antibody recognition and relevance.

    Blood·2026
    Same journal

    EBV and immunodeficiency: the odd couple drawn to the brain.

    Blood·2026
    Same journal

    A bone to pick with ferric carboxymaltose.

    Blood·2026
    Same journal

    A step toward streamlining HIT diagnosis.

    Blood·2026
    See all related articles

    Area of Science:

    • Hematology
    • Biochemistry
    • Molecular Biology

    Background:

    • Hypoprothrombinemia is a rare bleeding disorder characterized by low levels of prothrombin (factor II).
    • Prothrombin is a critical protein in the coagulation cascade, essential for blood clot formation.

    Observation:

    • A patient presented with a history of severe spontaneous and posttraumatic bleeding.
    • Laboratory analysis revealed markedly reduced prothrombin activity (9.5%) and antigen levels (5%).

    Findings:

    • Despite low quantitative levels, qualitative analysis using crossed immunoelectrophoresis and sucrose density gradient ultracentrifugation indicated the patient's prothrombin was structurally normal.
    • This suggests a functional defect in the patient's prothrombin molecule rather than a structural abnormality.

    Related Experiment Videos

    Implications:

    • This case highlights a potential functional deficiency in prothrombin, distinct from quantitative defects.
    • Further research into the specific functional defect could lead to novel diagnostic and therapeutic strategies for bleeding disorders.